参天製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2021/05/11 | 1,427 | 1,427 | 1,402 | 1,409 | -21 | -1.5% | 1,015,100 |
2021/05/10 | 1,408 | 1,433 | 1,408 | 1,430 | +21 | +1.5% | 790,000 |
2021/05/07 | 1,400 | 1,430 | 1,398 | 1,409 | +10 | +0.7% | 1,137,300 |
2021/05/06 | 1,425 | 1,428 | 1,399 | 1,399 | -1 | -0.1% | 1,477,800 |
2021/04/30 | 1,386 | 1,412 | 1,384 | 1,400 | ±0 | ±0% | 1,204,500 |
2021/04/28 | 1,408 | 1,415 | 1,394 | 1,400 | -27 | -1.9% | 1,472,100 |
2021/04/27 | 1,440 | 1,446 | 1,424 | 1,427 | -25 | -1.7% | 927,400 |
2021/04/26 | 1,459 | 1,462 | 1,439 | 1,452 | -11 | -0.8% | 837,000 |
2021/04/23 | 1,462 | 1,467 | 1,447 | 1,463 | +1 | +0.1% | 605,200 |
2021/04/22 | 1,447 | 1,463 | 1,440 | 1,462 | +23 | +1.6% | 934,700 |
2021/04/21 | 1,441 | 1,446 | 1,429 | 1,439 | -23 | -1.6% | 1,011,300 |
2021/04/20 | 1,478 | 1,478 | 1,457 | 1,462 | -30 | -2% | 980,600 |
2021/04/19 | 1,483 | 1,501 | 1,475 | 1,492 | +24 | +1.6% | 1,008,500 |
2021/04/16 | 1,468 | 1,473 | 1,461 | 1,468 | +1 | +0.1% | 692,000 |
2021/04/15 | 1,458 | 1,472 | 1,451 | 1,467 | +21 | +1.5% | 1,130,900 |
2021/04/14 | 1,453 | 1,460 | 1,439 | 1,446 | -5 | -0.3% | 1,297,200 |
2021/04/13 | 1,464 | 1,471 | 1,448 | 1,451 | +15 | +1% | 1,170,000 |
2021/04/12 | 1,480 | 1,481 | 1,412 | 1,436 | -74 | -4.9% | 3,677,300 |
2021/04/09 | 1,511 | 1,526 | 1,500 | 1,510 | -11 | -0.7% | 1,217,300 |
2021/04/08 | 1,522 | 1,530 | 1,509 | 1,521 | +13 | +0.9% | 1,301,300 |
2021/04/07 | 1,510 | 1,514 | 1,496 | 1,508 | +7 | +0.5% | 990,000 |
2021/04/06 | 1,517 | 1,521 | 1,492 | 1,501 | -18 | -1.2% | 998,300 |
2021/04/05 | 1,547 | 1,548 | 1,519 | 1,519 | -15 | -1% | 593,100 |
2021/04/02 | 1,539 | 1,543 | 1,528 | 1,534 | ±0 | ±0% | 728,200 |
2021/04/01 | 1,536 | 1,552 | 1,528 | 1,534 | +11 | +0.7% | 991,500 |
2021/03/31 | 1,489 | 1,532 | 1,489 | 1,523 | -2 | -0.1% | 1,615,200 |
2021/03/30 | 1,539 | 1,539 | 1,509 | 1,525 | -30 | -1.9% | 1,004,800 |
2021/03/29 | 1,556 | 1,566 | 1,536 | 1,555 | +16 | +1% | 1,619,400 |
2021/03/26 | 1,532 | 1,554 | 1,532 | 1,539 | +14 | +0.9% | 1,792,300 |
2021/03/25 | 1,529 | 1,532 | 1,496 | 1,525 | -15 | -1% | 2,044,000 |
2021/03/24 | 1,544 | 1,559 | 1,526 | 1,540 | -10 | -0.6% | 1,367,800 |
2021/03/23 | 1,560 | 1,567 | 1,547 | 1,550 | -15 | -1% | 2,012,100 |
2021/03/22 | 1,567 | 1,574 | 1,555 | 1,565 | -8 | -0.5% | 1,480,600 |
2021/03/19 | 1,555 | 1,576 | 1,549 | 1,573 | +19 | +1.2% | 2,206,500 |
2021/03/18 | 1,534 | 1,557 | 1,531 | 1,554 | +31 | +2% | 1,607,500 |
2021/03/17 | 1,520 | 1,523 | 1,504 | 1,523 | -1 | -0.1% | 1,199,100 |
2021/03/16 | 1,529 | 1,532 | 1,511 | 1,524 | +11 | +0.7% | 1,504,200 |
2021/03/15 | 1,489 | 1,513 | 1,481 | 1,513 | +20 | +1.3% | 1,585,000 |
2021/03/12 | 1,490 | 1,498 | 1,471 | 1,493 | +10 | +0.7% | 1,522,100 |
2021/03/11 | 1,451 | 1,496 | 1,446 | 1,483 | +37 | +2.6% | 3,095,100 |
2021/03/10 | 1,442 | 1,453 | 1,435 | 1,446 | -9 | -0.6% | 1,960,300 |
2021/03/09 | 1,439 | 1,459 | 1,429 | 1,455 | +43 | +3% | 2,072,300 |
2021/03/08 | 1,398 | 1,412 | 1,387 | 1,412 | +31 | +2.2% | 2,316,000 |
2021/03/05 | 1,384 | 1,392 | 1,370 | 1,381 | -19 | -1.4% | 3,573,800 |
2021/03/04 | 1,416 | 1,421 | 1,377 | 1,400 | -34 | -2.4% | 3,419,400 |
2021/03/03 | 1,424 | 1,440 | 1,390 | 1,434 | -24 | -1.6% | 2,259,500 |
2021/03/02 | 1,475 | 1,482 | 1,446 | 1,458 | -28 | -1.9% | 1,824,400 |
2021/03/01 | 1,462 | 1,488 | 1,462 | 1,486 | +24 | +1.6% | 1,208,500 |
2021/02/26 | 1,518 | 1,518 | 1,462 | 1,462 | -59 | -3.9% | 2,853,100 |
2021/02/25 | 1,549 | 1,556 | 1,521 | 1,521 | -9 | -0.6% | 1,077,300 |
1051~
1100
件表示中 / 3767件
類似銘柄と比較する
現在ご覧いただいている「参天薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
参天薬 | 157,600円 | -2.0% | -7.3% | 2.41% | 15.40倍 | 1.83倍 |
|
緑内障、加齢黄斑変性、ドライアイ治療薬など眼科用医薬品首位。一般用目薬「サンテ」が有名 |
ロート | 253,500円 | +8.4% | +6.4% | 1.66% | 18.19倍 | 2.20倍 |
|
一般用医薬品の目薬で世界首位。「肌研」が急成長しスキンケアが柱に。アジアなど海外積極進出 |
住友ファーマ | 143,800円 | -11.0% | +206.6% | 0.00% | 14.28倍 | 3.37倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
久光薬 | 430,000円 | +5.8% | +1.2% | 2.79% | 13.92倍 | 1.10倍 |
|
貼る鎮痛消炎剤首位。医療用シェア5割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
ツムラ | 364,700円 | +3.8% | -19.9% | 3.73% | 11.85倍 | 0.91倍 |
|
医療用漢方薬で国内シェア8割超。高齢者、がん支持療法、女性関連の3領域を重点に市場深耕 |
市場注目の銘柄
チャート関連のコラム